drugset
drugset / Trial / NCT03858543

Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

NCT03858543 ↗

Phase 0 Completed 10 enrolled Henry Ford Health System Galderma R&D · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).

Timeline

Start
2019-07-15
Primary completion
2021-01-31
Completion
2021-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Poly-L-Lactic Acid Small molecule — —

Indications

dermis disorder